Brand Name | Gilenya |
Generic Name | Fingolimod |
Drug Class | Sphingosine-1-Phosphate Receptor Modulator |
Availability | Prescription |
Manufacturer | Novartis |
Indications | Ulcerative Colitis |
Type | Capsule |
Doses | Initial: 0.5 mg daily; Maintenance: 0.5 mg daily |
Route | Oral |
Side Effects | Bradycardia, headache, liver enzyme elevation, infections |
Interactions | Avoid with immunosuppressants; increased infection risk |
Overdose | Unknown – investigational. |
Missed Dose | Unknown – investigational. |
Contraindications | Recent cardiovascular events, active infection |
Alternatives | Ozanimod, Etrasimod |
Co-Pay Assistance Program | Not available |
Patient Assistance Program | Available |
Fingolimod is primarily used to treat multiple sclerosis (MS) by reducing the frequency of MS attacks and slowing disease progression.
Fingolimod works by trapping certain white blood cells in lymph nodes, preventing them from attacking the brain and spinal cord, thus reducing inflammation.
Side effects of Fingolimod can include headaches, diarrhea, fatigue, and elevated liver enzymes. Serious effects may include heart problems or infections.
Fingolimod is taken orally once daily. Your doctor will prescribe the appropriate dose and may monitor you closely, especially when you start treatment.
Fingolimod is not recommended during pregnancy. If you are pregnant or planning to become pregnant, consult your healthcare provider before starting treatment.
Fingolimod can interact with other medications, especially those that affect heart rhythm or the immune system. Always inform your doctor about all medications you are taking.
If you miss a dose, take it as soon as you remember unless it�s almost time for your next dose. Do not double up on doses.
Fingolimod is primarily used for multiple sclerosis, but it is being studied for potential use in other autoimmune conditions under medical supervision.
Long-term use of Fingolimod may increase the risk of infections and liver issues. Your doctor will monitor you regularly for any potential side effects.
Fingolimod has been shown to reduce the frequency of MS relapses and slow disease progression, improving the quality of life for many patients.
Related Conditions |
Related Blogs |
---|---|